rs2777888
This variant is located in the CAMKV gene.
▶GWAS Catalog Trait Associations (5)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (5)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
body mass index
Harris BHL et al. “New role of fat-free mass in cancer risk linked with genetic predisposition.” Scientific Reports 14(1):7270 (2024)
Allele G
OR 0.03
p 3.0e-39
N 342,566
Large GWAS
European
fat pad mass
Harris BHL et al. “New role of fat-free mass in cancer risk linked with genetic predisposition.” Scientific Reports 14(1):7270 (2024)
Allele G
OR 0.03
p 6.0e-30
N 337,196
Large GWAS
European
lean body mass
Harris BHL et al. “New role of fat-free mass in cancer risk linked with genetic predisposition.” Scientific Reports 14(1):7270 (2024)
Allele G
OR 0.01
p 1.0e-18
N 337,739
Large GWAS
European
age at first birth measurement
Barban N et al. “Genome-wide analysis identifies 12 loci influencing human reproductive behavior.” Nature Genetics 48(12):1462-1472 (2016)
Allele A
OR 0.11
p 5.0e-15
N 238,064
Large GWAS
European
post-traumatic stress disorder symptom measurement
Stein MB et al. “Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program.” Nature Genetics 53(2):174-184 (2021)
Allele A
OR 0.09
p 2.0e-10
N 186,689
Major Consortium StudyLarge GWAS
European
▶ClinVar annotation
Benign★★★☆
2 submitters1 publicationAbout CAMKV
Predicted to enable calcium/calmodulin-dependent protein kinase activity and calmodulin binding activity. Predicted to be involved in signal transduction. Predicted to be located in cytoplasmic vesicle membrane and plasma membrane. Predicted to be active in cytoplasm; glutamatergic synapse; and postsynapse. [provided by Alliance of Genome Resources, Apr 2025]
View all CAMKV variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…